SEC Form 4 · accession 0001104659-15-000806
Ophthotech Corp. · OPHT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David R Guyer
Officer — Chief Executive Officer · Director
Period of report
Jan 2, 2015
Accepted (ET)
Jan 6, 2015 · 6:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410939
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 2, 2015 | M | 15,034 | $10.03 | A | 15,034 | D | |
| Common StockF2 | Jan 2, 2015 | S | 6,568 | $44.91 | D | 8,466 | D | |
| Common StockF3 | Jan 2, 2015 | S | 8,466 | $45.68 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F4 | $10.03 | Jan 2, 2015 | M | 15,034 | D | — | Apr 25, 2023 | Common Stock | 15,034 | 436,832 | D |
| Option (Right to Buy)F5 | $45.60 | Jan 2, 2015 | A | 91,500 | A | — | Jan 1, 2025 | Common Stock | 91,500 | 91,500 | D |
| Restricted Stock UnitsF6,F7 | — | Jan 2, 2015 | A | 23,000 | A | — | Jan 1, 2025 | Common Stock | 23,000 | 23,000 | D |
Explanation of responses
- F1The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2013.
- F2These shares were disposed of in multiple transactions on January 2, 2015 at actual sales prices ranging from $44.46 to $45.45 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3These shares were disposed of in multiple transactions on January 2, 2015 at actual sales prices ranging from $45.47 to $46.05 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4This option was granted on April 26, 2013 and vests as to 1/48 of the shares underlying such option each month until April 2017.
- F5Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, each of these stock option awards will vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.
- F6Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
- F7Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, each of these Restricted Stock Unit awards will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date.